CRISPR plants – what the EU Parliament got right and wrong

There is no doubt that this is good news: on February 7, the European Parliament approved the Commission’s regulatory proposal on New Genomic Techniques, covering also CRISPR plants. Some of the approved amendments (particularly the one on genetic modification of polyploid plants) have the effect of improving the text, others risk being a problem and should be reconsidered during the trilogue with member states (particularly the requirement to label all final products, even if they do not contain foreign genes). The European Parliament also brought in the issue of non-patentability of NGT plants, which would deserve to be addressed elsewhere. For more information, this is the position expressed on February 14 by European Plant Science Organisation (EPSO).

A multiple sclerosis trial and more CRISPR news

Anyone interested in advanced therapies is familiar with the acronym CAR-T. These are T lymphocytes modified (also with the help of CRISPR) to better recognize and attack cancer cells, and they have already proven to be a successful strategy for blood tumors. Now hopes are high that a similar approach may also prove useful for multiple sclerosis, which is an autoimmune disease. The idea is to use CAR-Ts to prevent B lymphocytes from attacking nerve cells, including in the brain. The first clinical trial is recruiting patients in the U.S. Read more in Nature.

Let’s come to the use of New Genomic Techniques in crops. The European Commission’s regulatory proposal (approved by the EU Parliament on Feb. 7) excludes the use of edited plants in organic farming, but among organic producers not everyone is against NGTs and this may bode well for a possible peaceful coexistence between the different types of production in the years to come.

Finally, we point out the latest advance in animal editing: porcine virus-resistant pigs. The paper came out in the CRISPR Journal, but you can also read about it in GEN.

CRISPR crops – Italy fires the starting gun

A CRISPR/Cas9-modified rice variety may be planted in a test field in northern Italy as soon as this spring after a government rule change introduced in 2023. A University of Milan team was the first research group in the country to apply for a field test under a law change that streamlines procedures for field trials of plants developed through genome editing or cisgenesis. With several other groups also planning proposals, a new wave of agricultural genetics in Italy could follow. [Please see the details in my article for Nature Italy]

A letter to Europe from CRISPR inventors and a thousand other scientists

Dear Members of the European Parliament, 

In these times of climate crisis, biodiversity loss and renewed food insecurity, a scientific and evidence-based approach is essential in every respect. Now more than ever, we must rise above ideology and dogmatism. That is why we the undersigned turn to you and urge you to carefully consider the benefits of embracing New Genomic Techniques (NGTs) in your upcoming parliamentary decisions. As concerned citizens who believe in the power of science to improve our lives and our relationship with the planet, we implore you to vote in favour of NGTs, aligning your decisions with the advancements in scientific understanding. Conventional breeding for climate resilient crops (with cross-breeding of certain traits, subsequent selection and then backcrossing to remove undesirable traits) is too time-consuming. It takes years, decades even. We do not have this time in an era of climate emergency.  

[Here you can read the full text of the letter and subscribe to it]

Organic farming & CRISPR – the not so odd couple

The New Genomic Techniques (NGTs) such as CRISPR are slowly rearranging the ranks in the debate on plant genetics and GM food. A few stakeholders that have always been hostile to GMOs have decided to open the door to the new opportunities coming from gene editing (in Italy, for example, the powerful farmers’ association Coldiretti has changed its mind). Others (e.g., Greenpeace, despite some isolated and courageous vanguards) have confirmed an ideological/cultural opposition, even in cases where the genetic intervention is so soft that the plants are concretely indistinguishable from those developed by conventional techniques. As for the galaxy of organic farming, it is standing still, yet something is moving. Don’t miss the article published in EUobserver by Lone Andersen and other organic farmers, who are calling on European institutions not to ban the new breeding techniques from their fields in the ongoing regulatory revision. “By encouraging the use of a limited share of the new NGTs in organic agriculture while preserving the non-GM status, the EU can further promote sustainable practices and reinforce its commitment to a greener future,” they write.

Hopes and worries in the CRISPR world

Credit Bing Image Creator

The news of the week is definitely this: the first clinical trial with base editing (the CRISPR platform used to chemically change single DNA letters without double-strand breaks) hit the goal of lowering cholesterol in patients but raised questions about the risks (with two serious adverse events, including one death), as Nature reports.

But we also recommend reading two other articles. Nature Biotechnology takes a look at experiments using CRISPR to eliminate viruses that manage to hide from the immune system, such as HIV and hepatitis. While Genetic Literacy Project publishes an analysis of the problems that could cripple the new regulation on edited plants proposed by the European Commission and delay (even until 2030) the arrival of the first products on the EU market.

CRISPR crops: the devil in the detail of the EU proposal

Image source: “How the EU risks falling behind in the bioeconomy revolution“, a report by the Breakthrough Institute and the Alliance for Science

The scientific community has warmly welcomed the proposal for partial deregulation of new genomic techniques put forward by the European Commission last July. Unfortunately, the legislative process will not be able to make significant progress before the next parliamentary term, which opens with the European elections in June 2024. However, this time will not be wasted if it serves to address a few problematic points and to finalise a few clarifying amendments. The devil is in the details: from the 20-nucleotide threshold proposed to delimit permissible interventions on the genome to the unknowns regarding coexistence with organic farming, not forgetting the stigma against herbicides. This article published in Nature Biotechnology by Belgian and German researchers is useful for going through the still unresolved issues.

Genetic gain is a team game

[The number of studies investigating the impact of modifying one or a few genes on the yield of a crop]

Some champions can make a difference, but to win matches and tournaments, there must be chemistry among the players. The same happens for the effort to increase the productivity of crop plants. Hunting down the single key gene, hoping it will work the miracle, is not enough. One must focus on the harmony of genetic combinations, through approaches that marry the most advanced technologies with agronomic knowledge. In short, handling DNA and test tubes is fine, but it is equally important to know what actually works when the plants reach the field. That’s the message a group of influential researchers such as Pamela Ronald of the University of California at Davis delivered to the pages of Nature in a commentary provocatively titled “Genetic modification can improve crop yields – but stop overselling it”.

Continue reading

Edited crops in EU – Have your say

The European Commission is collecting comments on the proposed regulation on New Genomic Techniques (NGTs) presented on 5 July. On this page you will find all the documents you need to form an opinion: from the criteria for establishing when a NGT plant is comparable to a conventional plant, to calculations on the costs of coexistence for organic producers (see in particular the Impact assessment report). The feedback received during the consultation period (8 weeks, extendable) will be summarised by the European Commission and presented to the European Parliament and the Council to feed into the legislative debate. In general, CRISPeR Frenzy appreciates the proposed regulation, especially for its focus on the promised benefits of NGTs in terms of environmental sustainability.